Equities research analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the software maker’s stock.
Separately, Stephens increased their price objective on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.
Read Our Latest Stock Analysis on Veradigm
Veradigm Stock Up 3.8 %
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- EV Stocks and How to Profit from Them
- Are Tariffs Threatening Disney’s Comeback Story?
- What is the NASDAQ Stock Exchange?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
